Sponsorship Statement: This continuing medical education activity is jointly sponsored by 
and 
Support Statement: This activity is supported by an educational grant from 
Target Audience: The intended audience for this activity is hematologists, hematologist/oncologists, and other health care professionals involved in treating patients with multiple myeloma.
Learning Objectives:
At the conclusion of this series, participants should be able to:
- Examine optimal frontline treatment strategies for patients with multiple myeloma using cytogenetics and molecular biomarkers
- Assess the efficacy, safety, and long-term outcomes associated with the use of various induction regimens for multiple myeloma patients who are eligible/ineligible to receive autologous stem cell transplantation.
- Recognize the most appropriate treatment options, including novel combinations and investigational novel drugs, for patients with relapsed and refractory multiple myeloma based on recent research data..
Course Chair:
Sergio A. Giralt, MD
Chief, Adult Bone Marrow Transplant Service
Memorial Sloan-Kettering Cancer Center
New York, NY
Faculty:
Heather J. Landau, MD
Bone Marrow Transplant Service
Memorial Sloan-Kettering Cancer Center
New York, NY
Antonio Palumbo, MD
Chief, Myeloma Unit
Department of Oncology
University of Torino
Torino, Italy
Accreditation:
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Vindico Medical Education and Cardiology Today®. Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Credit Designation:
Vindico Medical Education designates this enduring material for a maximum of 1.25 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This enduring material is approved for 1 year from the date of original release, February 1, 2012 to February 28, 2013.
How To Participate in this Activity and Obtain CME Credit:
To participate in this CME activity, you must read the objectives, read the articles, complete the CME posttest, and complete the evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 7 out of 9 of the posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)TM certificate.
External Reviewer:
William Matsui, MD
Medical Writer:
Lisa Tushla, PhD
Disclosures:
In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control. Relationship information appears on this page.
The authors disclose that they do have significant financial interests in any products or class of products discussed directly or indirectly in this activity, including research support.
Planning Committee and Faculty members report the following relationship(s):
Sergio A. Giralt, MD
Consulting Fees: Celgene, Novartis, Onyx
Heather J. Landau, MD
No relevant financial relationships to disclose.
Antonio Palumbo, MD
Consulting Fees: Celgene, Cilag, Janssen
Fees for Non-CME Services: Celgene, Cilag, Janssen
External reviewer reports the following relationship(s):
William Matsui, MD
No relevant financial relationships to disclose.
Medical Writers report the following relationship(s):
Lisa Tushla, PhD
No relevant financial relationships to disclose.
Anne Jacobson
No relevant financial relationships to disclose.
Steve Pridgeon
No relevant financial relationships to disclose.
Vindico Medical Education and HEMONC TODAY® staff report the following relationship(s):
No relevant financial relationships to disclose.
Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.
Unlabeled and Investigational Usage:
The audience is advised that this continuing medical education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non-FDA approved or investigational use of products/devices.
Copyright Statement:
Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-848-1000; Fax: 856-848-6091. Printed in the USA. Copyright © 2012 SLACK Incorporated®. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education and HEMONC TODAY® continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education and HEMONCTODAY®. Neither Vindico Medical Education, HEMONCTODAY®, nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.